• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Retinal vascular regeneration for diabetic macular edema by succinate & erythropoietin

Research Project

Project/Area Number 18K09404
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 56060:Ophthalmology-related
Research InstitutionKagawa University

Principal Investigator

Suzuma Kiyoshi  香川大学, 医学部, 教授 (80335265)

Co-Investigator(Kenkyū-buntansha) 宮田 学  京都大学, 医学研究科, 助教 (00548505)
大音 壮太郎  京都大学, 医学研究科, 講師 (10511850)
村上 智昭  京都大学, 医学研究科, 講師 (50549095)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords糖尿病網膜症 / エリスロポエチン / コハク酸
Outline of Final Research Achievements

Principle investigator (PI) moved to Ophthalmology, Kagawa University. PI set up cell culture system there, and introduced FLEXCELL cell extension system. It became possible to investigate effects of mechanical stress for intracellular signaling & retinal neovascularization in diabetic eye diseases. For human study, PI set up a system for sampling aqueous humor & vitreous for evaluation of cytokines or growth factors in diabetic macular edema & proliferative diabetic retinopathy. In addition, laser speckle flow graphy & retinal oxymap were introduced for real-time measurement for physiological retinal blood flow or oxygen saturation. New 2 technicians are employed for assistances.

Academic Significance and Societal Importance of the Research Achievements

コハク酸はVEGFだけでなくAng1などの血管安定化因子も誘導する必要不可欠な因子であることも報告されており正常な血管の再構築に役立つ因子である可能性がある。実験的網膜新生血管ではエリスロポエチンを阻害するとVEGF阻害と同等の抑制効果が得られ、VEGFとエリスロポエチンの両方を阻害するとさらに強い阻害効果が得られた。VEGFは血管増殖と血管透過性亢進の作用を有し、エリスロポエチンは血管透過性亢進作用をもたないことから増殖網膜症にはエリスロポエチンとVEGFの両者が、糖尿病黄斑症にはVEGFが主に関与しているということが示唆される。糖尿病網膜症の治療、社会的失明患者の減少に役立つ可能性がある。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (2 results)

All 2020

All Journal Article (2 results) (of which Peer Reviewed: 2 results,  Open Access: 1 results)

  • [Journal Article] Retinal Microvascular Resistance Estimated from Waveform Analysis Is Significantly Higher With a Threshold Value in Central Retinal Vein Occlusion.2020

    • Author(s)
      Matsumoto M, Suzuma K, Akiyama F, et al.
    • Journal Title

      Transl Vis Sci Technol

      Volume: 9(11) Issue: 11 Pages: 4-4

    • DOI

      10.1167/tvst.9.11.4

    • NAID

      120006988499

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema2020

    • Author(s)
      Yoshida Shigeo、Murakami Tomoaki、Nozaki Miho、Suzuma Kiyoshi、Baba Takayuki、Hirano Takao、Sawada Osamu、Sugimoto Masahiko、Takamura Yoshihiro、Tsuiki Eiko
    • Journal Title

      Graefe's Archive for Clinical and Experimental Ophthalmology

      Volume: 259 Issue: 4 Pages: 815-836

    • DOI

      10.1007/s00417-020-04936-w

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi